EX-FILING FEES 5 ex_508042.htm EXHIBIT FILING FEES ex_471047.htm

Exhibit 107

Calculation of Filing Fee Tables

Form S-3

(Form Type)

SAB Biotherapeutics, Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered Securities

 

Security
Type

Security Class

Title

 

Fee

Calculation

Rule

   

Amount

Registered(1)

   

Proposed

Maximum

Offering

Price Per

Unit

   

Maximum

Aggregate

Offering Price

   

Fee Rate

   

Amount of

Registration

Fee

 
Fees to Be Paid Equity 

Common Shares, no par value, underlying Warrants

    457(g)       300,000     $ 0.5424 (3)   $ 162,720       0.0001102     $ 17.93  
                                                     
 

Total Offering Amounts

            $ 162,720             $ 17.93  
                                                     
 

Total Fees Previously Paid

                               
                                                     
 

Total Fee Offsets

                               
                                                     
 

Net Fee Due

                            $ 17.93  

 

(1)

Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), the common shares offered hereby and the common shares issuable upon exercise of warrants also include an indeterminate number of additional common shares as may from time to time become issuable by reason of share splits, share dividends, recapitalizations or other similar transactions.

(2)

With respect to the common shares underlying the warrants offered by the selling stockholders, $0.5424 per share, which is the exercise price of the warrants, for purposes of calculating the registration fee pursuant to Rule 457(g) under the Securities Act.